ROIV

#566
Roivant Sciences Ltd. - Common Shares
30.3 2 USD
+1.47%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
29.94
30.42
Year Range
0.29
32.79
Daily Change
+1.47%
Monthly Change
+8.71%
6 month change
+48.05%
Year Change
+65.59%
Previous Close
29.8 8
Open
30.3 3
Low
29.9 4
High
30.4 2
Volume
673
Open full chart Full chart

Financials

Overview Statement Statistics
Quarterly Annual
  • Market Capitalization 21.81 B
  • Employee 750
  • Founded 2014
  • CEO Matt Gline
  • Website www.roivant.com
  • Headquarter Bermuda
  • FIGI N/A
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-51.3
Price to sales ratio
2 326.88

Roivant Sciences Ltd. - Common Shares

Roivant Sciences Ltd. is an American multinational healthcare company focused on applying technology to drug development and building subsidiary life sciences and health technology companies. It was founded in 2014 by Vivek Ramaswamy and is currently headed by CEO Matt Gline. Roivant maintains its headquarters in New York City as well as major offices in the biotech hubs of Boston and Basel.

News